KALA - Kala Pharmaceuticals Inc. (KALA) CEO Mark Iwicki on Q3 2020 Results - Earnings Call Transcript
Kala Pharmaceuticals, Inc. (KALA) Q3 2020 Earnings Conference Call November 05, 2020, 08:00 AM ET Company Participants Niranjan Kameswaran - SVP, Strategy Mary Reumuth - CFO Mark Iwicki - Chairman, President and CEO Kim Brazzell - Chief Medical Officer Todd Bazemore - COO Hongming Chen - Chief Scientific Office Conference Call Participants Liana Moussatos - Wedbush Securities Christopher Neyor - JPMorgan François Brisebois - Oppenheimer Yi Chen - H.C. Wainwright Presentation Operator Good morning, and welcome to the Kala Pharmaceuticals Third Quarter 2020 Financial Results Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the call over to Niranjan Kameswaran, Senior Vice President of Strategy for Kala Pharmaceuticals. Please proceed. Niranjan Kameswaran Thank you, operator, and thank you all for participating in today's call. Joining me from the company are: Mark Iwicki, Chairman, President and Chief Executive Officer; Todd Bazemore, Chief
For further details see:
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q3 2020 Results - Earnings Call Transcript